US Health Officials Block Publication of Study on COVID Vaccine Effectiveness

On April 22, 2026, researchers at the Centers for Disease Control and Prevention received a rejection letter from the agency's own flagship journal, the Morbidity and Mortality Weekly Report (MMWR), for a study that had already cleared internal scientific review [1][2]. The study found that the 2025-26 COVID-19 vaccine reduced emergency department visits and hospitalizations by roughly 50% among healthy adults [3]. The rejection came from acting CDC Director Jay Bhattacharya, who also serves as director of the National Institutes of Health, over stated concerns about the study's methodology [4].

The blocked study represents the latest in a series of clashes between career scientists and the political leadership installed at HHS under Secretary Robert F. Kennedy Jr. — clashes that have already led to the firing of the CDC's confirmed director, mass resignations of senior officials, the dismantling of the agency's vaccine advisory committee, and a federal court order blocking several of the resulting policy changes [5][6][7].

What the Study Found

The blocked report drew on data from the CDC-led VISION (Virtual SARS-CoV-2, Influenza, and Other respiratory viruses Network), a collaboration between the CDC, Westat, and multiple health systems that uses electronic health records from nine U.S. health systems to track vaccine effectiveness across age groups and care settings [8].

Between September and December 2025, the study found that vaccinated healthy adults had approximately 50% lower rates of COVID-associated emergency department and urgent care visits, and approximately 55% lower rates of COVID-associated hospitalizations, compared to unvaccinated adults [3][4]. These effect sizes are broadly consistent with previously published VISION data from the 2024-25 season, which found vaccine effectiveness against ED/urgent care visits of 33% (95% CI: 28%-38%) among adults 18 and older, and effectiveness against hospitalization of 45% (95% CI: 36%-53%) among immunocompetent adults 65 and older [9].

The slightly higher effectiveness estimates in the blocked 2025-26 study could reflect the updated vaccine formulation, the earlier time window studied, or normal seasonal variation — questions that peer review and publication would ordinarily help resolve.

Source: CDC / NCHS

Data as of Jun 1, 2024CSV

The Methodology Dispute

The stated reason for the rejection centers on the study's use of a "test-negative design" — a widely used epidemiological method in which researchers compare the vaccination status of patients who test positive for a respiratory virus against those who test negative, measuring whether vaccinated individuals are less likely to appear in the positive group [4][10].

An HHS spokesperson said the "MMWR's editorial assessment identified concerns regarding the methodological approach to estimating vaccine effectiveness and the manuscript was not accepted for publication" [1]. Bhattacharya "expressed concerns about the observational method used in this study to calculate vaccine effectiveness," according to an HHS official [4].

The test-negative design has been used by the CDC for years to evaluate vaccine effectiveness against seasonal respiratory viruses. A study on flu vaccine effectiveness using the same methodology was published in the MMWR on March 12, 2026 — just weeks before the COVID vaccine study was rejected [2][3]. A VISION study on COVID-19 vaccine effectiveness in children, also using test-negative design, was published in the MMWR in December 2025 [9].

"This seems like pretty aggressive interference by a political appointee into CDC scientific processes," said Dr. Fiona Havers, who resigned as senior vaccine policy adviser at the CDC in June 2025 [2]. She called the rejection "pretty problematic in general, because it's a very standard, well-established study design that has been used for a long time" [1].

Dr. Demetre Daskalakis, former director of the CDC's National Center for Immunization and Respiratory Diseases, called the action "cherry picking based on the bias of the director" and said that "suppressing the standard of science on VE [vaccine efficacy] to wait for a perfect study... is not a hallmark of transparent scientific expertise" [3][10]. Former CDC chief medical officer Dr. Debra Houry stated that "in general, their methodology was appropriate and has been used in other studies" [4].

Bhattacharya has not publicly elaborated on what specific aspects of the test-negative design he finds problematic, or why those concerns apply to COVID vaccine research but not to flu vaccine research conducted with the same method.

The Steelman Case for Delay

Test-negative designs do have known limitations. They are observational, not randomized, and can be affected by confounders — for instance, people who choose to get vaccinated may differ from those who do not in health-seeking behavior, underlying health status, or prior infection history. These are well-documented methodological caveats that researchers routinely address in their analyses and that peer reviewers evaluate.

A genuine concern about methodological rigor — if that is what Bhattacharya intended — would ordinarily result in a request for revisions, additional analyses, or caveats in the text. The MMWR has a formal review process for exactly this purpose. What distinguishes this episode is that the paper was not sent back for revision. It was rejected outright after having already cleared internal scientific review [1][2].

No specific patient privacy risks or national security concerns have been cited by HHS officials in connection with the study.

A Pattern of Political Interference

The rejected study did not arrive in isolation. It is part of a broader pattern of political intervention in CDC science that has accelerated since early 2025.

Communication restrictions: In February 2025, CDC scientists were barred from publishing certain research as new layers of review from political appointees were imposed [11]. CBS News reported that Trump administration officials had taken "unprecedented" steps to exert influence over the MMWR, including dictating what topics the journal should cover [12].

ACIP overhaul: In June 2025, Kennedy removed all 17 members of the Advisory Committee on Immunization Practices (ACIP) and replaced them with seven new appointees, at least three of whom had spoken out against mRNA COVID-19 vaccines, and two of whom had served as witnesses in lawsuits against vaccine manufacturers [5][6]. The reconstituted panel declined to recommend COVID-19 vaccines even for high-risk populations [6].

CDC director firing: Susan Monarez, confirmed as CDC director by the Senate on July 29, 2025, was fired by President Trump on August 27 — less than a month later — after she refused Kennedy's demands to pre-approve ACIP recommendations and dismiss career vaccine policy officials. "I was fired for holding the line on scientific integrity," Monarez testified before a Senate committee in September 2025 [13][14]. Kennedy disputed her account and said she had been removed because she was not trustworthy [15].

Senior resignations: Dr. Havers resigned in June 2025, writing that she no longer had "confidence that these data will be used objectively or evaluated with appropriate scientific rigor to make evidence-based vaccine policy decisions" [16]. Daskalakis resigned in August 2025, accusing Kennedy's administration of "radical non-transparency" and "unskilled manipulation of data to achieve a political end" [17]. At least four additional senior CDC officials resigned in protest during the same period [14].

Court intervention: In March 2026, U.S. District Court Judge Brian Murphy blocked the reconstituted ACIP's decisions, ruling that Kennedy had improperly replaced the entire committee, and invalidated votes the new panel had taken, including those downgrading COVID-19 and hepatitis B vaccine recommendations [7]. In April 2026, HHS rewrote the ACIP charter in what experts said was an effort to sidestep the court order [18][19].

Historical Precedent for MMWR Interference

Political interference with the MMWR has precedent, though at a smaller scale. During the first Trump administration in 2020, political appointees at HHS attempted to change, delay, or remove COVID-19 reports from the MMWR that undermined President Trump's claims about the outbreak. Charlotte Kent, the MMWR's editor, later testified that she had been ordered to destroy an email from a political appointee demanding changes to a previously published report [12][20].

A 2020 JAMA editorial on the subject noted that the MMWR "has long been recognized as needing to be free of political influence" for its scientific reports to maintain public trust [20]. Prior to the pandemic, draft MMWR article summaries had never been shared outside the CDC — an undocumented but longstanding tradition intended to protect editorial independence [12].

Who Is Making Decisions Without This Data

The suppressed study covers a period during which millions of Americans were making decisions about COVID-19 vaccination. As of early 2026, only 17.5% of U.S. adults had received the 2025-26 COVID-19 vaccine [21]. Among adults 65 and older — the group at highest risk of severe COVID — uptake stood at 30.8% [21]. For children, the figure was 9.4% [21].

Source: CDC COVIDVaxView

Data as of Apr 4, 2026CSV

These already low uptake numbers exist in a context where the federal government has actively narrowed vaccine recommendations. In May 2025, Kennedy announced that COVID-19 vaccines would no longer be recommended for pregnant women and healthy children [5]. The reconstituted ACIP — before being blocked by a federal judge — voted against recommending COVID vaccines even for high-risk populations [6].

Individuals making decisions about boosters, protection for immunocompromised family members, or return-to-work protocols during the winter of 2025-26 did so without access to the federal government's own data showing that the vaccine cut their risk of hospitalization roughly in half. Whether any specific adverse outcomes resulted from this information gap is inherently difficult to quantify, but the principle at stake — that the public should have access to data collected with public funds about products they are being asked to evaluate — is not in dispute among mainstream public health experts.

How Other Countries Handle This

The question of government suppression of public health research is not unique to the United States, but the U.S. approach stands out among peer democracies.

In the United Kingdom, a 2016 inquiry into missing evidence found that government departments were routinely preventing the release of commissioned research. Since 2023, the registration of all clinical trials and publication of results is compulsory under UK law [22].

In Australia, a survey published in 2023 documented 142 instances of government suppression of public health information, with governments succeeding in suppressing the targeted research 87% of the time [23].

In Germany, heavily redacted public health institute files on vaccine advice drew public criticism for undermining confidence in vaccine policy [24].

None of these countries, however, have a direct analogue to the MMWR — a government-published scientific journal with decades of institutional credibility. The U.S. has not codified a legal standard governing when political officials may override scientific editorial processes at federal agencies, leaving the question to norms that the current administration has shown willingness to discard.

Academic Research in Decline

The suppression of this study occurs against a backdrop of declining academic output on COVID vaccine effectiveness. Peer-reviewed publications on the topic peaked at 33,857 papers in 2023 and have fallen sharply, with only 5,137 papers published so far in 2026 — a 76% decline from the prior year [25].

Source: OpenAlex

Data as of Jan 1, 2026CSV

This decline partly reflects the natural arc of pandemic research. But it also means that the CDC's own surveillance data, including studies like the one now blocked, represents an increasingly important share of the available evidence on vaccine effectiveness for current vaccine formulations.

Legal Remedies and Oversight

Researchers whose work has been suppressed have limited options. The CDC's FOIA office was effectively shuttered in April 2025, when 22 staff members were placed on administrative leave. HHS Secretary Kennedy also laid off FOIA staff at the FDA and NIH [26][27]. Congressional Democrats have demanded answers about the elimination of FOIA processing capacity, calling it an effort "to prevent the public from obtaining information about their government" [26].

The authors of the blocked study could submit it to an independent medical journal, though the data belongs to the CDC's VISION network and publication outside the agency may raise questions about data access and approval.

Congressional oversight hearings have addressed the broader pattern of interference — Monarez testified before a Senate committee in September 2025 [13] — but no specific legislative remedy for MMWR editorial independence has been introduced.

Federal whistleblower protections exist for government scientists who disclose waste, fraud, or abuse, but invoking them carries professional risk. Several of the officials who have spoken out — Havers, Daskalakis, Monarez — did so only after leaving or being removed from their positions.

What Comes Next

The rejected study's authors could seek publication in an external peer-reviewed journal such as the New England Journal of Medicine or The Lancet, where the test-negative design is standard and accepted. Whether they can do so using CDC data without agency approval remains an open question.

The federal court order blocking the reconstituted ACIP's decisions is being contested by HHS. The rewritten ACIP charter, which broadens the committee's scope to include vaccine injuries and loosens qualification requirements for members, may represent an attempt to reconstitute the panel on different legal footing [18][19].

The practical consequence for the public is straightforward: a federal study showing that COVID-19 vaccines cut hospitalizations roughly in half during the 2025-26 winter season exists, has passed internal scientific review, and cannot be read by the people whose tax dollars funded it.